Deadline for submission is December 1, 2023.
Notification of Acceptance is January 1, 2024.
- Abstracts have to be submitted exclusively online.
- Authors can submit their abstracts for poster presentation and oral presentation.
- Submitted abstracts can only be modified prior to the submission deadline.
- The presenting author must be listed first and must be the author that submits the abstract.
Topic, Language
- Abstracts must be submitted and presented in English.
Size, Content
- The abstract body is limited to 300 words.
- The title should be written in standard sentence style with lower case letters (except first word, names, human gene names [always upper-case letters & italics], etc.).
- The text should be grammatically suitable for publication.
- Special characters can be included during submission.
- Non-standard abbreviations must be defined in the text.
- Abstracts must not be used to promote specific drugs, instruments etc.
- Submitted abstracts must provide results and not announcements; stating that “Findings will be discussed…” or similar is not acceptable.
- The usage of special formatting should be limited. The correct replication in all media cannot be guaranteed.
Conditions, Requirements
The presenter is responsible for compliance with data protection, copyrights, ethical regulations and laws.
- The abstract should be novel. It is acceptable to submit abstracts related to information already reported at another conference or in a journal provided that new information will also be presented. The authors should declare this during submission and make clear the new information that will be presented. Please tick the appropriate box “Parts of the data have been published previously”.
- To secure anonymity of the review process, names and locations should not be disclosed in the abstract.
Review, Registration
- All submitted abstracts will be reviewed by several experts.
- Evaluation criteria are: Aim(s) and objective(s), materials and methodology, results and conclusions.